These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study. Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB. Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979 [Abstract] [Full Text] [Related]
5. Diagnostic Accuracy of HemotypeSC as a Point-of-Care Testing Device for Sickle Cell Disease: Findings from a Southwestern State in Nigeria and Implications for Patient Care in Resource-Poor Settings of sub-Saharan Africa. Olatunya OS, Albuquerque DM, Fagbamigbe AF, Faboya OA, Ajibola AE, Babalola OA, Adebisi AO, Falusi AG, Adekile A, Costa FF. Glob Pediatr Health; 2021 Jul; 8():2333794X211016789. PubMed ID: 34046518 [Abstract] [Full Text] [Related]
7. Feasibility Study of the "HemoTypeSC" Test for the Rapid Screening of Sickle Cell Disease in Côte D'Ivoire. Kakou Danho JB, Atiméré YN, Koné D, Yéo DD, Couitchéré L. Adv Hematol; 2021 Jul; 2021():8862039. PubMed ID: 33790971 [Abstract] [Full Text] [Related]
9. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood. Guindo A, Cisse Z, Keita I, Desmonde S, Sarro YDS, Touré BA, Baraika MA, Tessougué O, Guindo P, Coulibaly M, Traore O, Sylla N, Diassana M, Saye A, Picot V, Lauressergues E, Leroy V. Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227 [Abstract] [Full Text] [Related]
15. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia. Mano RM, Kuona P, Misihairabgwi JM. BMC Pediatr; 2024 May 10; 24(1):323. PubMed ID: 38730340 [Abstract] [Full Text] [Related]
16. Diagnostic accuracy in field conditions of the sickle SCAN® rapid test for sickle cell disease among children and adults in two West African settings: the DREPATEST study. Segbena AY, Guindo A, Buono R, Kueviakoe I, Diallo DA, Guernec G, Yerima M, Guindo P, Lauressergues E, Mondeilh A, Picot V, Leroy V. BMC Hematol; 2018 May 10; 18():26. PubMed ID: 30237894 [Abstract] [Full Text] [Related]
18. Pairing parents and offspring's HemoTypeSC Test to validate results and confirm sickle cell pedigree: a case study in Kisangani, the Democratic Republic of the Congo. Kasai ET, Kadima JN, Alworong'a Opara JP, Boemer F, Dresse MF, Makani J, Bours V, Marini Djang'eing'a R, Paul KK, Batina Agasa S. Hematology; 2022 Dec 10; 27(1):853-859. PubMed ID: 35938952 [Abstract] [Full Text] [Related]
19. Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update. Kasai ET, Gulbis B, Ntukamunda JK, Bours V, Batina Agasa S, Marini Djang'eing'a R, Boemer F, Katenga Bosunga G, Ngbonda Dauly N, Sokoni Vutseme J, Boso Mokili B, Alworong'a Opara JP. Hematology; 2023 Dec 10; 28(1):2213043. PubMed ID: 37183964 [Abstract] [Full Text] [Related]
20. [HemoTypeSC screening for sickle cell disease in the Democratic Republic of Congo (DRC): a case from the city of Kindu]. Aimé AK, Etienne SM, Mbongi D, Nsonso D, Serrao E, Léon TMM, Oscar LN, Stanis WO. Pan Afr Med J; 2022 Dec 10; 41():134. PubMed ID: 35519159 [Abstract] [Full Text] [Related] Page: [Next] [New Search]